Compare Stocks: ZSQR, VTEX, OOMA, and HKD

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HKD AMTD Digital	$1.70 +0.9%	$1.64	$1.26 ▼ $5.47	$534.62M	1.98	355,516 shs	35,538 shs
OOMA Ooma	$23.24 +3.2%	$20.71	$9.79 ▼ $26.19	$640.34M	1.2	304,074 shs	174,031 shs
VTEX VTEX	$3.65 +1.3%	$3.98	$2.84 ▼ $4.73	$621.44M	0.99	1.23 million shs	478,066 shs
ZSQR Coeptis Therapeutics	$3.08 +1.0%	$5.85	$2.81 ▼ $21.41	$163.24M	-0.25	267,730 shs	232,077 shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HKD AMTD Digital	+0.30%	-0.88%	+1.20%	-5.87%	+5.51%
OOMA Ooma	+2.92%	+9.64%	+4.72%	+29.78%	+73.68%
VTEX VTEX	+0.14%	-0.96%	-17.75%	-2.98%	-10.41%
ZSQR Coeptis Therapeutics	+4.81%	-30.05%	-40.66%	-71.99%	-76.43%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HKD AMTD Digital	$1.70 +0.9%	$1.64	$1.26 ▼ $5.47	$534.62M	1.98	355,516 shs	35,538 shs
OOMA Ooma	$23.24 +3.2%	$20.71	$9.79 ▼ $26.19	$640.34M	1.2	304,074 shs	174,031 shs
VTEX VTEX	$3.65 +1.3%	$3.98	$2.84 ▼ $4.73	$621.44M	0.99	1.23 million shs	478,066 shs
ZSQR Coeptis Therapeutics	$3.08 +1.0%	$5.85	$2.81 ▼ $21.41	$163.24M	-0.25	267,730 shs	232,077 shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HKD AMTD Digital	+0.30%	-0.88%	+1.20%	-5.87%	+5.51%
OOMA Ooma	+2.92%	+9.64%	+4.72%	+29.78%	+73.68%
VTEX VTEX	+0.14%	-0.96%	-17.75%	-2.98%	-10.41%
ZSQR Coeptis Therapeutics	+4.81%	-30.05%	-40.66%	-71.99%	-76.43%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
HKD AMTD Digital	1.00	Sell	N/A	N/A
OOMA Ooma	2.83	Moderate Buy	$25.00	7.57% Upside
VTEX VTEX	2.33	Hold	$4.69	28.60% Upside
ZSQR Coeptis Therapeutics	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest ZSQR, VTEX, OOMA, and HKD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/28/2026	VTEX VTEX	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target	Overweight ➝ Equal Weight	$4.00
8/27/2026	OOMA Ooma	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
8/27/2026	VTEX VTEX	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$5.10
8/27/2026	OOMA Ooma	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$25.00
8/27/2026	OOMA Ooma	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$24.00 ➝ $27.00
8/27/2026	OOMA Ooma	Alliance Global Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
8/25/2026	VTEX VTEX	Itau BBA Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform ➝ Market Perform	$4.50
8/17/2026	OOMA Ooma	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$24.00
8/17/2026	OOMA Ooma	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
8/14/2026	ZSQR Coeptis Therapeutics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E-)
8/7/2026	VTEX VTEX	Bradesco Corretora Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Neutral	$4.50

(Data available from 9/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
HKD AMTD Digital	$136.10M	3.93	$0.26 per share	6.41	$2.45 per share	0.69
OOMA Ooma	$306.59M	2.08	$1.09 per share	21.33	$3.37 per share	6.90
VTEX VTEX	$240.52M	2.58	$0.14 per share	26.83	$1.31 per share	2.78
ZSQR Coeptis Therapeutics	$1.36M	120.03	N/A	N/A	$2.50 per share	1.23

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
HKD AMTD Digital	$54.71M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
OOMA Ooma	$6.46M	$0.38	61.28	25.54	N/A	3.57%	23.89%	10.97%	N/A
VTEX VTEX	$20.01M	$0.16	22.78	14.58	0.47	11.98%	12.98%	8.76%	11/5/2026 (Estimated)
ZSQR Coeptis Therapeutics	-$11.92M	-$1.63	N/A	N/A	N/A	-773.72%	-49.45%	-46.88%	N/A

Latest ZSQR, VTEX, OOMA, and HKD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/26/2026	Q2 2027	OOMA Ooma	$0.3314	$0.35	+$0.0186	$0.10	$81.72 million	$83.23 million
8/13/2026	Q2 2026	ZSQR Coeptis Therapeutics	N/A	-$0.28	N/A	-$0.28	N/A	$1.58 million
8/7/2026	Q2 2026	VTEX VTEX	$0.0459	$0.0580	+$0.0121	$0.0580	$64.69 million	$64.39 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
HKD AMTD Digital	N/A	N/A	N/A	N/A	N/A
OOMA Ooma	N/A	N/A	N/A	N/A	N/A
VTEX VTEX	N/A	N/A	N/A	N/A	N/A
ZSQR Coeptis Therapeutics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
HKD AMTD Digital	N/A	N/A	N/A
OOMA Ooma	0.50	0.94	0.69
VTEX VTEX	0.02	2.91	2.91
ZSQR Coeptis Therapeutics	N/A	7.66	7.66

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
HKD AMTD Digital	5.75%
OOMA Ooma	80.42%
VTEX VTEX	63.69%
ZSQR Coeptis Therapeutics	13.88%

Insider Ownership

Company	Insider Ownership
HKD AMTD Digital	N/A
OOMA Ooma	9.90%
VTEX VTEX	40.93%
ZSQR Coeptis Therapeutics	24.25%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
HKD AMTD Digital	50	315.41 million	N/A	Not Optionable
OOMA Ooma	1,420	27.50 million	24.78 million	Optionable
VTEX VTEX	1,139	170.49 million	100.71 million	Optionable
ZSQR Coeptis Therapeutics	2	53.00 million	40.15 million	Not Optionable

ZSQR, VTEX, OOMA, and HKD Headlines

Recent News About These Companies

Z Squared CEO to Shareholders: "The Scarcest Thing in AI is Not Chips. It is Power.

August 14, 2026 | prnewswire.com

Coeptis Therapeutics (NASDAQ:ZSQR) Issues Quarterly Earnings Results

August 13, 2026 | marketbeat.com

Z Squared Inc. Signs Definitive Agreement to Acquire 100% of Paradox Data and Its Union County Campus

August 3, 2026 | prnewswire.com

Z Squared Inc. Terminates At-The-Market Sales Agreement and Committed Equity Forward Purchase Agreement

July 17, 2026 | prnewswire.com

Z Squared Inc. Provides Capital Structure Update

July 15, 2026 | prnewswire.com

Z Squared Inc. Appoints Jeffrey Harris as Chief Technology Officer

June 30, 2026 | prnewswire.com

Z Squared Raises Approximately $15.3 Million in Non-Debt Capital to Advance AI Infrastructure Strategy

June 29, 2026 | prnewswire.com

Russell Indexes Add Z Squared Inc. to Russell 2000® and Russell 3000®

June 29, 2026 | prnewswire.com

Z Squared, Inc. to Acquire Majority Interest in Paradox Data and Its Union County Campus, a Next-Generation Data Center Development Targeting Up to 150 MW of Firm Power

June 25, 2026 | prnewswire.com

Z Squared to Participate in Maxim Group's AI Data Center Summit

June 9, 2026 | prnewswire.com

Z Squared, Inc. Enters $50 Million Committed Equity Forward Purchase Agreement to Support AI Infrastructure Buildout

June 4, 2026 | prnewswire.com

Z Squared, Inc. Announces Preliminary Inclusion in Russell 3000® and Russell 2000® Indexes

May 27, 2026 | prnewswire.com

Vanderbilt Report: Z Squared Locks In Zero-Cash, Zero-Debt Path to 42 MW of AI-Ready Power

May 26, 2026 | globenewswire.com

Z Squared, Inc. Outlines Phase 1 Plan to Reach 100 MW of AI-Ready Infrastructure for Inference Workloads

May 19, 2026 | prnewswire.com

Z Squared Appoints Jon Najarian, Pete Najarian, Marc LoPresti and Jay Zapata to Newly Formed Advisory Board

May 4, 2026 | prnewswire.com

Z Squared to Acquire Skycore Digital, Adding 24 MW of Energized AI Infrastructure with Expansion Path to 42 MW

April 29, 2026 | prnewswire.com

Z Squared, Inc. to Ring the Nasdaq Closing Bell in Celebration of Its Listing on the Nasdaq Global Market

April 28, 2026 | prnewswire.com

Coeptis Therapeutics Announces Approval of Z Squared Inc.'s Nasdaq Listing Application

April 27, 2026 | finanznachrichten.de

Z Squared Provides Additional Information on Previously Disclosed Pro Rata Distribution

April 27, 2026 | tmcnet.com

Coeptis Therapeutics Receives Shareholder Approval Towards Z Squared Merger

April 27, 2026 | finanznachrichten.de

Z Squared Inc.: Z Squared Announces Completion of Business Combination with Coeptis Therapeutics and Listing on the Nasdaq Global Market

April 25, 2026 | finanznachrichten.de

New MarketBeat Followers Over Time

Media Sentiment Over Time

ZSQR, VTEX, OOMA, and HKD Company Descriptions

AMTD Digital NYSE:HKD

$1.70 +0.02 (+0.89%)

As of 02:25 PM Eastern

AMTD Digital Inc., through its subsidiaries, designs and develops a digital platform to provide financial, media, content and marketing, and investment solutions in Asia. The company operates through Digital Solutions ServicesFinancial Services, Digital Solutions ServicesNon Financial Services, Digital Media, Content, and Marketing Services, and Digital Investments segments. It offers deposit, personal loan, credit card, fund transfer, cross border remittance, insurance, and other payment services. In addition, the company operates SpiderNet ecosystem, a platform to enhance their investor communication, investor relations, and corporate communication to enhance their valuation. Further, it offers movies, podcasts, webinars, and videos through online media platforms. Additionally, the company invests in hotel related activities. AMTD Digital Inc. was incorporated in 2019 and is based in Paris, France. AMTD Digital Inc. operates as a subsidiary of AMTD IDEA Group.

Ooma NYSE:OOMA

$23.24 +0.71 (+3.15%)

As of 02:27 PM Eastern

Ooma, Inc. provides communications services and related technologies for businesses and consumers in the United States and Canada. The company's products and services include Ooma Office, a cloud-based multi-user communications system for small and medium-sized businesses; Ooma Connect, which delivers fixed wireless internet connectivity; and Ooma Enterprise, a unified-communications-as-a-service (UCaaS) solution. It also provides Ooma AirDial, a plain old telephone service; PureVoice HD, a residential phone services; Ooma basic that provides unlimited personal calling within the United States; and Ooma Premier, a suite of advanced calling features on a monthly or annual subscription basis. In addition, the company offers Ooma Telo, a home communications solution designed to serve as the primary phone line in the home; Ooma Telo Air, a wireless Ooma Telo with built-in Wi-Fi and Bluetooth; and Ooma Telo LTE, which combines the Ooma Telo base station with the Ooma LTE Adapter and battery back-up. Further, it provides Ooma Mobile HD app that allows users to make and receive phone calls and access Ooma features and settings; 2600Hz provides business communication applications; Talkatone mobile app; and OnSIP, an UCaaS solutions. The company offers its products through direct sales, distributors, retailers, and resellers, as well as online and sale representatives. Ooma, Inc. was incorporated in 2003 and is headquartered in Sunnyvale, California.

VTEX NYSE:VTEX

$3.64 +0.05 (+1.25%)

As of 02:27 PM Eastern

VTEX provides software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce strategy, including building online stores, integrating, and managing orders across channels, and creating marketplaces to sell products from third-party vendors. It has operations in Brazil, Argentina, Chile, Colombia, France, Italy, Mexico, Peru, Portugal, Romania, Singapore, Spain, the United Kingdom, and the United States. VTEX was founded in 2000 and is headquartered in London, the United Kingdom.

Coeptis Therapeutics NASDAQ:ZSQR

$3.08 +0.03 (+0.98%)

As of 02:12 PM Eastern

Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological malignancies and solid tumors; and CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy. The company also offers its drugs for acute myeloid leukemia and acute respiratory diseases. Coeptis Therapeutics Holdings, Inc. has co-development agreement Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. The company was founded in 2017 and is headquartered in Wexford, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ZSQR, VTEX, OOMA, and HKD Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ZSQR, VTEX, OOMA, and HKD Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ZSQR, VTEX, OOMA, and HKD Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ZSQR, VTEX, OOMA, and HKD Company Descriptions

AMTD Digital NYSE:HKD

Ooma NYSE:OOMA

VTEX NYSE:VTEX

Coeptis Therapeutics NASDAQ:ZSQR

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ZSQR, VTEX, OOMA, and HKD Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ZSQR, VTEX, OOMA, and HKD Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ZSQR, VTEX, OOMA, and HKD Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ZSQR, VTEX, OOMA, and HKD Company Descriptions

AMTD Digital NYSE:HKD

Ooma NYSE:OOMA

VTEX NYSE:VTEX

Coeptis Therapeutics NASDAQ:ZSQR

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools